Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jul;9(4):299-306.
doi: 10.4168/aair.2017.9.4.299.

Emerging Endotypes of Chronic Rhinosinusitis and Its Application to Precision Medicine

Dae Woo Kim  1 , Seong H Cho  2
Affiliations
Review

Emerging Endotypes of Chronic Rhinosinusitis and Its Application to Precision Medicine

Dae Woo Kim et al. Allergy Asthma Immunol Res. 2017 Jul.

Abstract

Chronic rhinosinusitis (CRS) is a heterogeneous inflammatory disease with various underlying pathophysiologic mechanisms which translate to endotypes, in contrast to clinical phenotypes or histological subtypes. Defining endotypes can help clinicians predict disease prognosis, select subjects suitable for a specific therapy, and assess risks for comorbid conditions, including asthma. Therefore, with recent advancement of biologicals in CRS clinical trials, endotyping can be a breakthrough in treating recalcitrant CRS. CRS is caused by dysregulated immunologic responses to external stimuli, which induce various inflammatory mediators from inflammatory cells, including innate lymphoid cells (ILCs) and T lymphocytes as well as epithelial cells. Thymic stromal lymphopoietin (TSLP), interleukin (IL)-25, and IL-33, which are mainly secreted by epithelial cells in response to external stimuli, act on type 2 ILCs and T helper 2 (Th2) cells, inducing IL-4, IL-5, and IL-13. Local immunoglobulin E (IgE) production is also a signature event in nasal polyps (NP). These inflammatory mediators are novel potential therapeutic targets for recalcitrant CRS. This article reviews recent publications regarding endotypes and endotype-based therapeutic strategies in CRS and NP.

Keywords: Nasal polyps; biologicals; chronic rhinosinusitis; cytokines; endotypes; phenotypes.

PubMed Disclaimer

Conflict of interest statement

There are no financial or other issues that might lead to conflict of interest.

Figures

Figure
Figure. Endotypes and biologicals of CRS with NP. CRS, chronic rhinosinusitis; NP, nasal polyps.
See this image and copyright information in PMC

References

    1. Kim DH, Han K, Kim SW. Effect of chronic rhinosinusitis with or without nasal polyp on quality of life in South Korea: 5th Korea National Health and Nutrition Examination Survey Korean. Clin Exp Otorhinolaryngol. 2016;9:150–156. - PMC - PubMed
    1. Wang X, Zhang N, Bo M, Holtappels G, Zheng M, Lou H, et al. Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: a multicenter study in Europe, Asia, and Oceania. J Allergy Clin Immunol. 2016;138:1344–1353. - PubMed
    1. Kim DW, Kim JY, Jeon SY. The status of the olfactory cleft may predict postoperative olfactory function in chronic rhinosinusitis with nasal polyposis. Am J Rhinol Allergy. 2011;25:e90–e94. - PubMed
    1. Cho SH, Bachert C, Lockey RF. Chronic rhinosinusitis phenotypes: an approach to better medical care for chronic rhinosinusitis. J Allergy Clin Immunol Pract. 2016;4:639–642. - PMC - PubMed
    1. Zhang L, Zhang L, Zhang CH, Fang XB, Huang ZX, Shi QY, et al. The lung function impairment in non-atopic patients with chronic rhinosinusitis and its correlation analysis. Clin Exp Otorhinolaryngol. 2016;9:339–345. - PMC - PubMed